SIGN UPLog In

Last deal

$20M

Amount

Series A

Stage

20.11.2019

Date

2

all rounds

$29.2M

Total amount

General

About Company
Lucence Health is a liquid biopsy company that detects cancer hallmarks for earlier detection and targeted treatment.

Industry

Sector :

Subsector :

Also Known As

Lucence

founded date

01.04.2016

Number of employees

51-100

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company invents advanced cancer diagnostics through its total liquid biopsy approach and sensitive blood-testing technologies, which accurately and affordably profile cancer, improving cancer diagnosis and treatment selection for physicians and patients.
Contacts

location

Palo Alto, CA, USA

Phone number

Website URL

https://www.lucence.com/

Social url